0.7007
Schlusskurs vom Vortag:
$0.683
Offen:
$0.6898
24-Stunden-Volumen:
18,066
Relative Volume:
0.13
Marktkapitalisierung:
$20.28M
Einnahmen:
$26.55M
Nettoeinkommen (Verlust:
$-91.72M
KGV:
-0.1955
EPS:
-3.584
Netto-Cashflow:
$-13.25M
1W Leistung:
+10.29%
1M Leistung:
-3.58%
6M Leistung:
-46.10%
1J Leistung:
-78.44%
Celularity Inc Stock (CELU) Company Profile
Firmenname
Celularity Inc
Sektor
Branche
Telefon
(908) 768-2170
Adresse
170 PARK AVE, FLORHAM PARK
Compare CELU vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CELU
Celularity Inc
|
0.7007 | 21.74M | 26.55M | -91.72M | -13.25M | -3.584 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
|
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-30 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-06 | Herabstufung | Truist | Buy → Hold |
| 2022-01-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Celularity Inc Aktie (CELU) Neueste Nachrichten
CELU|Celularity Inc|Price:0.780|Chg%:+0.030 - TradingKey
Celularity Inc (CELU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Celularity Inc (CELU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Philip & Daniele Barach Family Trust Net Worth (2026) - GuruFocus
Celularity Inc. (CELU) warrants delisted and deregistered from Nasdaq exchange - Stock Titan
Press Release: Celularity Appoints Rick Gonzalez as Chief Commercial Officer - Moomoo
Number of shareholders of Celularity Inc. – NASDAQ:CELUW - TradingView
Price to sales forward of Celularity Inc. – NASDAQ:CELUW - TradingView
CELU Q4 2025 Earnings: Narrower-Than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et
Celularity Inc. Warrant 2021-16.07.26 on Celularity -A- Financial Disclosures & SEC Filings - TradingView
Celularity Inc. Announces Resignation of Vincent LeVien as Director, Effective June 26, 2026 - marketscreener.com
Celularity Inc. Enters into a Loan Agreement with the Philip & Daniele Barach Family Trust - marketscreener.com
Celularity Company Profile & Introduction - Moomoo
Celularity Inc. Secures $1 Million Loan from Philip & Daniele Barach Family Trust – Form 8-K Filing Details and Key Agreement Terms 141519 - Minichart
CELULARITYSECURES $1 MLN LOAN FROM PHILIP & DANIELE BARACH FAMILY TRUSTSEC FILING - Moomoo
Celularity director Vincent LeVien resigns from board - TradingView
Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term - Stock Titan
Celularity Secures $1 Million Bridge Loan From Barach Family Trust, Due in 30 Days or Financing - TradingView
Celularity Inc (NASDAQ: CELU) Share Price, CELU Stock News, CELU Share Price & Updates - Kalkine
Enterprise value to EBIT forward of Celularity Inc. – NASDAQ:CELU - TradingView
Enterprise value to EBITDA forward of Celularity Inc. – NASDAQ:CELU - TradingView
Price to sales forward of Celularity Inc. – NASDAQ:CELU - TradingView
Price to earnings forward of Celularity Inc. – NASDAQ:CELU - TradingView
Celularity Appoints Chief Operating Officer - Moomoo
Celularity Strengthens Leadership With New Executive Appointments - The Globe and Mail
Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary - TradingView
New leadership at Celularity (NASDAQ: CELU) as Gordon joins board - Stock Titan
Celularity Inc. Class A Actuals & Estimates (NASDAQ:CELU) - TradingView
Celularity Inc. (CELU) Q4 2025 Earnings: Narrowed Loss Beats Estimates, but Revenue Remains AbsentDiluted EPS Report - DonanımHaber
Form 4 Celularity Inc For: 23 June By Investing.com - Investing.com South Africa
Barach Family Trust (CELU) lets $2M note, warrant options lapse while holding large derivatives - Stock Titan
Celularity (NASDAQ: CELU) insider trust sees $2M note option expire - Stock Titan
Celularity (NASDAQ: CELU) major holder’s $2M note option and 839K warrants expire - Stock Titan
Form 13D/A Celularity Inc. For: 23 June By Investing.com - Investing.com Australia
Barach Family Trust updates 15.8% Celularity (CELU) stake in 13D/A - Stock Titan
CELU Technical Analysis & Stock Price Forecast - Intellectia AI
Penny Stocks: Why Is Celularity (CELU) Stock Trending Today? - TipRanks
Celularity Inc (CELUW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Celularity Inc (CELUW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELUW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELUW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELUW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELUW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celularity Inc (CELUW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELUW) Institutional Confidence - TradingKey
Finanzdaten der Celularity Inc-Aktie (CELU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Celularity Inc-Aktie (CELU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Haines John R | Senior Exec Vice President |
Apr 13 '26 |
Option Exercise |
0.00 |
1,641 |
0 |
30,762 |
| Hariri Robert J | Chief Executive Officer |
Apr 13 '26 |
Option Exercise |
0.00 |
3,281 |
0 |
2,854,735 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):